Published in Cancer Weekly, May 21st, 2002
ColorectAlert, developed by IMI International Medical Innovations, Inc., detects a cancer-associated sugar in a mucus sample. The health economic study comparing ColorectAlert with the current standard test - fecal occult blood test (FOBT) - was presented at the Canadian Association for Population Therapeutics meeting in Toronto and the abstract is published in the current issue of the Canadian Journal of Clinical Pharmacology.
The study modeled a theoretical screening program for a population of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.